Amanda C. Guidon - Concepedia

Author

Amanda C. Guidon

Also Known As

A Guidon, A. Guidon, A.C. Guidon, Amanda C Guidon, Amanda C. Guidon, Amanda Guidon, Andrew L Mammen, Angela Genge, Patricia Flynn, Utsugisawa, Kimiaki

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Yale University Duke University Brigham and Women's Hospital

About

Amanda C. Guidon is an author at Massachusetts General Hospital specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Cell Biology	2	2	238
3	Health Sciences	1	1	15
4	Cellular Physiology	1	1	67
5	Epidemiology	1	1	197

Amanda C. Guidon

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Divyanshu Dubey, William S. David, Kerry L. Reynolds, Annals of Neurology Timely ManagementDisease ProgressionSevere Neurological ToxicityImmunodeficienciesImmunology	2020	229
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors Amanda C. Guidon, Leeann B Burton, Bart K. Chwalisz, Journal for ImmunoTherapy of Cancer ImmunodeficienciesImmunologyPathologyConsensus Disease DefinitionsImmunotherapy	2021	197
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis Douglas B. Johnson, Wyatt J. McDonnell, Paula I. González-Ericsson, Nature Medicine ImmunologyAntiviral ResponsePathologyAutoimmunityT Cell Immunity	2019	171
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies Divyanshu Dubey, William S. David, Anthony A. Amato, Neurology ImmunologyPathologyInflammatory Neuropathy CauseImmunotherapyNeuroinflammation	2019	162
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon, Journal of the Neurological Sciences	2020	154
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) Srikanth Muppidi, Jeffrey T. Guptill, Saiju Jacob, The Lancet Neurology	2020	121
<scp>COVID</scp>‐19 in patients with myasthenia gravis Pria Anand, Michaël C. C. Slama, Michelle Kaku, Muscle & Nerve	2020	116
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis John S. Yi, Amanda C. Guidon, Sara D. Sparks, Journal of Autoimmunity ImmunologyAntigen ProcessingAutoimmunityMusk Myasthenia GravisCellular Immune Response	2014	67
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis Jeffrey T. Guptill, John S. Yi, Donald B. Sanders, Neurology Neuroimmunology & Neuroinflammation	2015	64

Page 1